Blog
Ferguson Share Repurchase Program - Weekly Report
Ferguson plc (NYSE: FERG, LSE: FERG) (the “Company”) announces today that it purchased a total of 43,846 of its ordinary shares in the period from July 10, 2023, up to and including July 14, 2023
Lelio Gavazza Appointed CEO of TOM FORD FASHION
Ermenegildo Zegna N.V. (NYSE: ZGN) (“Zegna Group,” the “Group,” “Zegna,” or the “Company”), today announced the appointment of Lelio Gavazza to the newly created position of CEO, TOM FORD FASHION
Poxel Announces Upcoming Participation at the H.C. Wainwright 2nd Annual Kidney Conference
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Jack in the Box Announces Third Quarter 2023 Earnings Webcast
Jack in the Box, Inc. (NASDAQ: JACK) announces the following event:
What:
JACK Q3 2023 Earnings Webcast
When:
Wednesday, August 9 at 11:00 a.m
Marcus & Millichap Releases Special Report on Industrial Outdoor Storage Properties
Marcus & Millichap (NYSE:MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, has published a special report on
Civitas Resources, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call
Civitas Resources, Inc. (NYSE: CIVI) (“Civitas” or the “Company”), today announced plans to release its second quarter 2023 operating and financial results after market close on Wednesday, August
Power Integrations to Release Second-Quarter Financial Results on August 3
Power Integrations (Nasdaq: POWI) will release its second-quarter financial results after market hours on Thursday, August 3, 2023, and will host a conference call that day beginning at 1:30 p.m
Acadia Healthcare Opens the First of Two Hospitals Developed in Partnership With Geisinger
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the opening of its newest operating joint venture hospital, Geisinger Behavioral Health Center Northeast, located in Moosic
Granite REIT Declares Distribution for July 2023
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2667 per stapled unit for the month of
Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for
Advance Auto Parts Comments on TRC Capital “Mini-Tender” Offer
Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider in North America, that serves both professional installer and do-it-yourself customers, has been notified that
T-Mobile Takes the Limelight in Latest Industry Expert Report
Now playing “We are the Champions.” Ookla, the global leader in network intelligence and connectivity insights, today shared a report confirming T-Mobile’s (NASDAQ: TMUS) network remains undefeated
ExxonMobil to Release Second Quarter 2023 Financial Results
Exxon Mobil Corporation (NYSE: XOM) will release its second quarter 2023 financial results on Friday, July 28, 2023. The company will issue a press release via Business Wire, and it will be
Median Technologies to Host Two Webcasts and Provide a Company Update on July 20, 2023
Regulatory News:
Median Technologies (Euronext Growth - ALMDT) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on July 20, 2023 during
Median Technologies Announces Onboarding of All Academic Sites Involved in the Pivotal Validation Plan for iBiopsy® LCS CADe/CADx SaMD
Regulatory News:
Median Technologies (ALMDT) announces today that the Company has officially commenced operations with all investigator sites participating in the pivotal validation plan for its
Transgene Receives $15.3 Million from the Sale of Securities Held for Sale
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that it has received $15.3
U.S. Cybersecurity Strategies Zero in on Business Outcomes
U.S. enterprises are responding to growing cybersecurity threats by working to make the best use of tools and services to ensure business resilience, according to a new research report published
Fluor Team Awarded DOE Portsmouth Gaseous Diffusion Plant Decontamination and Decommissioning Contract
Fluor Corporation (NYSE: FLR) announced today that the U.S. Department of Energy (DOE) selected Southern Ohio Cleanup Company, LLC, a joint venture led by Amentum with Fluor and Cavendish Nuclear
PGTI University celebrates 100th podcast episode
PGT Innovations (NYSE: PGTI), a national leader in the premium window, door, and garage door industry, recently announced PGTI University, the company’s customer-focused education team, celebrated
AGCO Announces Second-Quarter 2023 Earnings Release and Conference Call
AGCO, Your Agriculture Company, (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, announced today its second-quarter
American States Water Company to Report Second Quarter 2023 Results
American States Water Company (NYSE:AWR) announced today that the company intends to release its second quarter ended June 30, 2023 financial results after the market closes on Monday, August 7
Cognex Announces Second Quarter Earnings Release Date and Conference Call
Cognex Corporation (NASDAQ: CGNX) will release earnings for the second quarter of 2023 on Thursday, August 3, 2023, before the market opens, and will host a conference call that same day at 8:30
Homes Are Selling for Near-Record Highs as Supply Falls to New Low, Demand Picks Up
(NASDAQ: RDFN) — A record low number of homes for sale combined with an uptick in homebuyer demand propped up housing prices in June, even as elevated mortgage rates kept many buyers on the
Vistagen Reports New Preclinical Data Supporting Itruvone (PH10) Nasal Spray’s Potential Antidepressant Activity via Peripheral Nasal Neurons without Entry into the Brain
Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system


